Yazar "Karabudak, Rana" için listeleme
-
Bir grup multipl skleroz hastasında ve birinci derece akrabalarında ek otoimmün hastalık varlığının araştırılması
Acar, Nazire Pınar; Badak, Esra; Turgut, Seda; Uyanık, Saliha; Evran, Saliha; Savran, Emine; Karabudak, Rana (2008)AMAÇ: Otoimmün yolaklarla gittiği düşünülen bir hastalık olan Multipl Skleroz (MS) benzer yolakları kullanan otoimmün hastalıklarla birlikte görülebilmektedir. AMAÇ: Bu tanımlayıcı çalışmada Ankara ve Samsun merkezlerinde ... -
A clinically isolated syndrome: A challenging entity
Kurne, Asli; Isikay, Ilksen Colpak; Karlioguz, Kader; Kalyoncu, Umut; Aydin, Omer Faruk; Calguneri, Meral; Karabudak, Rana (Springer Heidelberg, 2008)Acute isolated neurological syndromes, such as optic neuropathy or transverse myelopathy, may cause diagnostic problems since they can be the first presentations of a number of diseases such as multiple sclerosis (MS) and ... -
Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis
Boz, Cavit; Terzi, Murat; Ozer, Bilge; Turkoglu, Recai; Karabudak, Rana; Efendi, Husnu; Ozakbas, Serkan (Elsevier Sci Ltd, 2019)Background: Fingolimod and teriflunomide are commonly used in the treatment of relapsing-remitting multiple sclerosis (RRMS). These have not been compared in controlled trials, but only in observational studies, with ... -
Interferon-beta Theraphy in Multiple Sclerosis Patients: is Response Age Dependent?
Kurne, Asli; Terzi, Murat; Aydin, Oemer Faruk; Onar, Musa Kazim; Karabudak, Rana (Journal Neurological Sciences, 2009)The onset of Multiple sclerosis (MS) is usually between 20 and 40 years and in those patients, beta-interferons reduce relapse frequency in a rate of 30%. The purpose of this study was to compare the therapeutical response ... -
Lack of association of the CD14/C-159T polymorphism with susceptibility and progression parameters in Turkish multiple sclerosis patients
Kurne, Asli; Sayat, Guliz; Aydin, Omer Faruk; Turgutoglu, Nihan; Terzi, Murat; Sackesen, Cansin; Karabudak, Rana (Elsevier Science Bv, 2012)Soluble (s) CD14, being a receptor for lipopolysaccharides (LPSs) may inhibit LPS-triggered apoptosis and T lymphocyte proliferation. C to T exchange at position - 159 in the promoter region of the CD14 gene might lead to ... -
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort Demographic, Clinical, and Laboratory Features
Altintas, Ayse; Karabudak, Rana; Balci, Belgin P.; Terzi, Murat; Soysal, Aysun; Saip, Sabahattin; Siva, Aksel (Lippincott Williams & Wilkins, 2015)Background: Neuromyelitis optica (NMO) is an immune-mediated, chronic relapsing, inflammatory disease characterized by severe attacks of optic neuritis and myelitis. Objective: To determine the demographic, clinical, and ... -
TRAIL and BAFF serial serum levels during interferon beta therapy in MS patients
Kurne, Asli; Canpinar, Hande; Aydin, Oemer F.; Sayat, Gueliz; Yoeruebulut, Mehmet; Guec, Dicle; Karabudak, Rana (Sage Publications Ltd, 2008)… -
White matter alteration in a patient with Graves' disease
Kurne, Asli; Aydin, Oemer Faruk; Karabudak, Rana (Sage Publications Inc, 2007)A case of Graves' disease with white matter abnormalities is presented here. The diagnosis as Graves' disease was made when the patient was 5 years old, and a subtotal thyroidectomy was performed when she was 10. Her ...
